Goldman Jonathan

0.8

0.8

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Avalo Therapeutics, Inc. (AVTX)

Transaction date 2 Jun 2026

Proposed sale

Price

161.55

Quantity 96,429

Value US$2,653,656

Avalo Therapeutics, Inc. (AVTX)

Transaction date 14 Nov 2025

Sale

Price

199.11

Quantity 41,194 +24.8%

Value US$3,270,747

Comments Filing

Avalo Therapeutics, Inc. (AVTX)

Transaction date 14 Nov 2025

Sale

Price

325.48

Quantity 6,799 -4.7%

Value US$2,707,559

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-06-02	2026-06-02	Avalo Therapeutics, Inc. (AVTX)	PrS Proposed sale	96,429 161.55 US$2,653,656	96,429	161.55	US$2,653,656
2025-11-17	2025-11-14	Avalo Therapeutics, Inc. (AVTX)	S Sale	41,194 +24.8% 199.11 US$3,270,747	41,194 +24.8%	199.11	US$3,270,747
2025-11-17	2025-11-14	Avalo Therapeutics, Inc. (AVTX)	S Sale	6,799 -4.7% 325.48 US$2,707,559	6,799 -4.7%	325.48	US$2,707,559